Boothbay Fund Management’s Gossamer Bio GOSS Stock Holding History

Boothbay Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,719	Closed	-$426K	–	2225
2025 Q4	$426K	Buy	+1,719	New	+$392K	0.01%	1229
2020 Q1	–	Sell	-16	Closed	-$2.02M	–	926
2019 Q4	$2.02M	Buy	16 +9	+129%	+$14.5K	0.18%	157
2019 Q3	$888K	Buy	+7	New	+$11.1K	0.08%	336

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Boothbay Fund Management's GOSS Position: Q1 2024 in Review

Boothbay Fund Management sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 729 shares — an estimated $53.2K sold.

Boothbay Fund Management first reported a position in GOSS in Q1 2019 and held it in 12 quarters. The position peaked at $1.69M in Q3 2021. 108 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

Boothbay Fund Management reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
Boothbay Fund Management sold 729 Gossamer Bio shares in Q1 2024, an estimated $53.2K.
Boothbay Fund Management first reported a position in Gossamer Bio in Q1 2019 and held it in 12 quarters.
Boothbay Fund Management's Gossamer Bio position peaked at $1.69M in Q3 2021.
108 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.